Trial intelligence / Profile preview

Moxidectin for Onchocerciasis

NCT00300768Phase 2Completed

Sponsor
Medicines Development for Global Health
Start
Sep 2006
Primary completion
Nov 2009
Modality
Allosteric Modulators
Countries
1
01

Overview

A Phase 2 trial of moxidectin in onchocerciasis, sponsored by Medicines Development for Global Health. Started Sep 2006; status: completed.

02

Drugs

moxidectin
03

Conditions

onchocerciasis

Beyond the preview

Go deeper on NCT00300768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00300768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call